The world is caught in a perfect storm of rising rates of chronic disease, persistent infectious diseases and public health failures that have fuelled deaths in the Covid-19 pandemic, according to a major global study of human health.
The U.S. Centers for Disease Control and Prevention (CDC) asked state public health officials to prepare to distribute a potential coronavirus vaccine to high-risk groups as soon as late October, documents published by the agency showed.
Alphabet Inc.’s Google and Apple Inc. announced a new system that will enable public health authorities to use smartphones to assist in contact tracing without having to build an app.
Former U.S. Food and Drug Administration Commissioner Scott Gottlieb criticized current FDA Commissioner Stephen Hahn’s comments to the Financial Times that he would potentially fast-track a Covid-19 vaccine before clinical trials are done if it was “appropriate.”
The U.S. government said pharmacists would be allowed to administer routine vaccines to children, calling a drop in immunization from lockdowns aimed at curbing the spread of the coronavirus a “public health threat.”
With billions of doses of Covid-19 expected to be available by year’s end, and a global population of 7.8 billion, public health officials are scrambling to deliver the vaccines in ways that are equitable and effective. The challenge is about more than having a vaccine, and more than delivering it, public health experts at Johns Hopkins Medical School explained during a media briefing.
A new $1 billion fund backed by 20 drugmakers including Merck & Co. Inc. and Pfizer Inc. is aiming to bolster struggling antibiotic companies and sustain a pipeline for new treatments.
The United States surpassed Italy on Saturday as the country with the highest reported coronavirus death toll, recording more than 20,000 deaths since the outbreak began, according to a Reuters tally.
Join Ipsos for an interactive, complimentary “Ask us anything” webinar examining how public mood is changing as a result of Covid-19, where concerns are most focused now, and how the crisis is affecting American’s behavior now and in the future.
The U.S. Food and Drug Administration is putting a halt to the sale of alleged treatments for COVID-19 due to concerns about the safety risks these products could have to the public.